Raffles Medical Group Insider Transactions: CEO Buys $1.5M Worth of Shares
ByAinvest
Thursday, Mar 13, 2025 7:02 pm ET1min read
BSL--
Loo's recent purchase, although increasing his holding size by only 0.7%, is a noteworthy development given the size of the transaction. Moreover, this purchase was not an isolated incident; earlier in the year, Loo invested S$3.6 million in purchasing shares at an average price of S$1.03 per share [1].
The fact that an insider was willing to buy shares at above the current market price of S$0.91 suggests a positive outlook on the company's future prospects. This sentiment is further reinforced by the longer-term insider transactions, which indicate a significant level of alignment between management and shareholders [1].
Raffles Medical Group insiders currently own approximately 15% of the company, which is valued at around S$253 million based on the recent share price [1]. This level of insider ownership is generally considered a positive sign, as it increases the likelihood that the company is being managed in the best interests of all shareholders.
In conclusion, the recent insider buying activity at Raffles Medical Group, particularly by Executive Chairman and CEO Choon Yong Loo, is a positive sign for shareholders. The fact that insiders are willing to invest their own funds in the company at above market prices suggests a strong belief in its future prospects.
References:
[1] SimplyWallSt. (2022, September 30). Raffles Medical Group Insider Transactions Over The Last Year. Retrieved October 13, 2022, from https://simplywall.st/stocks/sg/healthcare/sgx-bsl/raffles-medical-group-shares/news/choon-yong-loo-buys-handful-of-shares-in-raffles-medical-gro
SG--
Raffles Medical Group insiders have been net buyers of the stock over the past 12 months, with the Executive Chairman & CEO Choon Yong Loo making the biggest insider purchase of S$1.5m worth of shares at S$0.89 each. Insiders own 15% of the company, indicating a high level of alignment between management and shareholders.
Raffles Medical Group Ltd (SGX:BSL) has recently witnessed significant insider buying activity, with Executive Chairman and CEO Choon Yong Loo leading the charge. Over the past 12 months, Loo has purchased a total of S$2.53 million worth of shares, with the latest acquisition amounting to S$1.5 million at an average price of S$0.89 [1].Loo's recent purchase, although increasing his holding size by only 0.7%, is a noteworthy development given the size of the transaction. Moreover, this purchase was not an isolated incident; earlier in the year, Loo invested S$3.6 million in purchasing shares at an average price of S$1.03 per share [1].
The fact that an insider was willing to buy shares at above the current market price of S$0.91 suggests a positive outlook on the company's future prospects. This sentiment is further reinforced by the longer-term insider transactions, which indicate a significant level of alignment between management and shareholders [1].
Raffles Medical Group insiders currently own approximately 15% of the company, which is valued at around S$253 million based on the recent share price [1]. This level of insider ownership is generally considered a positive sign, as it increases the likelihood that the company is being managed in the best interests of all shareholders.
In conclusion, the recent insider buying activity at Raffles Medical Group, particularly by Executive Chairman and CEO Choon Yong Loo, is a positive sign for shareholders. The fact that insiders are willing to invest their own funds in the company at above market prices suggests a strong belief in its future prospects.
References:
[1] SimplyWallSt. (2022, September 30). Raffles Medical Group Insider Transactions Over The Last Year. Retrieved October 13, 2022, from https://simplywall.st/stocks/sg/healthcare/sgx-bsl/raffles-medical-group-shares/news/choon-yong-loo-buys-handful-of-shares-in-raffles-medical-gro

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet